TP53BP1 and breast cancer: Intriguingly, loss of 53BP1, observed in 20% of PARPi-resistant breast cancer PDXs, mechanistically restores HR by allowing the access of DNA nucleases (Cruz et al. 2018; Waks et al. 2020).